Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/Core EBITDA

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 22.1930.2832.74-0.120.23

What is the latest EV/Core EBITDA ratio of MANKIND PHARMA ?

The latest EV/Core EBITDA ratio of MANKIND PHARMA is 22.19 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202622.19
Mar202530.28
Mar202432.74
Mar2023-0.12
Mar20220.23

How is EV/Core EBITDA of MANKIND PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 22.19
-26.72
Mar2025 30.28
-7.51
Mar2024 32.74
Positive
Mar2023 -0.12
Negative
Mar2022 0.23 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/Core EBITDA ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹103,274.8 Cr 2.2% -6.5% -10.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr -0.1% -6.5% 3.8% Stock Analytics
DIVIS LABORATORIES ₹251,611.0 Cr -0.2% -5.5% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,182.0 Cr 0.4% -8.2% 25.2% Stock Analytics
CIPLA ₹109,063.0 Cr 1.7% -2% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,926.0 Cr 4.9% 7.7% -2.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.2%

-6.5%

-10.5%

SENSEX

-0.3%

-1.6%

-12.3%


You may also like the below Video Courses